Oxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and Polyps
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Morningstar5 天
Oxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and Polyps
Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...
Oxford BioDynamics, Plc: Oxford BioDynamics' EpiSwitch CRC Blood Test Accurately Detects ...
Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...
emjreviews.com5 天
Family History of Frequent Polyps Linked to Increased Risk of Colorectal Cancer
Study reveals a higher frequency of polyp diagnoses in relatives increases the risk of colorectal cancer, especially ...
London South East5 天
CRC Test Accurately Detects Cancer and Polyps
Dr Alexandre Akoulitchev, OBD's Chief Scientific Officer added: "Reliable and non-invasive detection of early stages of colorectal cancer, as well as the polyps, has been the focus of strenuous ...
Oxford BioDynamics upbeat on publication of EpiSwitch study
Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal ...